Erratum to “Endovascular Repair of Acute Uncomplicated Aortic Type B Dissection Promotes Aortic Remodelling: 1 Year Results of the ADSORB Trial” [Eur J Vasc Endovasc Surg 48 (3) (September/2014) 285–291]
2015; Elsevier BV; Volume: 50; Issue: 1 Linguagem: Inglês
10.1016/j.ejvs.2015.04.014
ISSN1532-2165
AutoresJan Brunkwall, Piotr M. Kasprzak, Eric L.G. Verhoeven, Robin Heijmen, Peter Taylor, Pierre Alric, Ludovic Canaud, M. Janotta, D. Raithel, Martin Malina, Timothy Resch, Hans‐Henning Eckstein, S. Ockert, Thomas Larzon, Fredrik Carlsson, H. Schumacher, S. Classen, Peter Schaub, Johannes Lämmer, Lars Lönn, R.E. Clough, Vincenzo Rampoldi, Santi Trimarchi, Jean‐Noël Fabiani, D. Böckler, Drosos Kotelis, Hendrik von Tengg‐Kobligk, Nicola Mangialardi, Sonia Ronchey, Giovanni Dialetto, Vladimir Matoussevitch,
Tópico(s)Cardiac, Anesthesia and Surgical Outcomes
ResumoThe publisher regrets the following errors in the original article:•The spelling of the name of ADSORB Trialist member Hendrik von Tengg-Kobligk is corrected as given here.•The names of ADSORB Trialists D. Böckler and D. Kotelis should not be duplicated in the author list. The publisher would like to apologise for any inconvenience caused. Endovascular Repair of Acute Uncomplicated Aortic Type B Dissection Promotes Aortic Remodelling: 1 Year Results of the ADSORB TrialEuropean Journal of Vascular and Endovascular SurgeryVol. 48Issue 3PreviewUncomplicated acute type B aortic dissection (AD) treated conservatively has a 10% 30-day mortality and up to 25% need intervention within 4 years. In complicated AD, stent grafts have been encouraging. The aim of the present prospective randomised trial was to compare best medical treatment (BMT) with BMT and Gore TAG stent graft in patients with uncomplicated AD. The primary endpoint was a combination of incomplete/no false lumen thrombosis, aortic dilatation, or aortic rupture at 1 year. Full-Text PDF Open Archive
Referência(s)